Contracts › SPE2DP26F4183
SPE2DP26F4183: 8512025830!Antidote Treatment
Awarded to Meridian Medical Technologies, Llc by Defense Logistics Agency (DLA).
$36.5Mobligated
$36.5Mpotential value
26 February 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | SPE2DP26F4183 |
|---|---|
| Vehicle | SPE2DP26D0001 |
| Awardee | Meridian Medical Technologies, Llc |
| Awarding agency | Defense Logistics Agency (DLA) |
| Awarding office | DLA TROOP SUPPORT |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | MO |
| Period of performance | 07 April 2026 to 26 February 2027 |
| Potential end | 26 February 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record